Long-Term Treatment With Morphine Increases the D-Serine Content in the Rat Brain by Regulating the mRNA and Protein Expressions of Serine Racemase and D-Amino Acid Oxidase
スポンサーリンク
概要
- 論文の詳細を見る
- Japanese Pharmacological Societyの論文
- 2008-07-20
著者
-
Kobayashi Hiroyuki
Department Of Pediatric Surgery Juntendo Univ
-
川口 充
東京歯科大学・口腔科学研究センター薬理学講座
-
Shinomiya Takashi
Department of Pharmacology, Tokyo Dental College, Japan
-
Kawaguchi Mitsuru
Department of Pharmacology, Tokyo Dental College, Japan
-
Yoshikawa Masanobu
Department of Pharmacology, Tokyo Dental College, Japan
-
Takahashi Shigeru
Department Of Pharmacology Tokyo Dental College
-
Kawaguchi Mitsuru
Department Of Pharmacology And Oral Health Science Center Tokyo Dental College
-
Kawaguchi Mitsuru
Department Of Pharmacology Tokyo Dental College
-
Yoshikawa Masanobu
Department Of Clinical Pharmacology School Of Medicine Tokai University
-
Yoshikawa Masanobu
Department Of Applied Physics Faculty Of Engineering Osaka University
-
OKA Tetsuo
Departmnet of Orthopedics, Asahikawa Medical College
-
HASHIMOTO Atsushi
Department of Chemical Engineering, Division of Applied Chemistry, Tokyo University of Agriculture &
-
Hashimoto Atsushi
Department Of Chemical Engineering Division Of Applied Chemistry Tokyo University Of Agriculture &am
-
Takahashi Shigeru
Laboratory Of Environmental Molecular Physiology School Of Life Sciences Tokyo University Of Pharmac
-
Tsukamoto Hideo
Laboratories for Structure and Function Research, Tokai University School of Medicine
-
Kobayashi Hiroyuki
Department Of Applied Chemistry Saitama University
-
Oka T
Department Of Clinical Pharmacology School Of Medicine Tokai University
-
Oka Tetsuo
Department Of Pharmacology School Of Medicine Tokai University
-
Tsukamoto Hideo
Laboratory For Molecular Science Research Tokai University School Of Medicine
-
Tsukamoto Hideo
Laboratories For Structure And Function Research Tokai University School Of Medicine
-
Yoshikawa Masaaki
Department Of Clinical Pharmacology School Of Medicine Tokai University
-
TAKAYASU Naoko
Laboratory for Molecular Science Research, Tokai University School of Medicine
-
Takayasu Naoko
Laboratory For Molecular Science Research Tokai University School Of Medicine
-
Kurose Hitoshi
Department Of Pharmacology And Toxicology Graduate School Of Pharmaceutical Sciences Kyushu Universi
-
Kobayashi Hiroyuki
Department Of Clinical Pharmacology School Of Medicine Tokai University
-
Hashimoto Atsushi
Department Of Clinical Pharmacology Tokai University School Of Medicine
-
Hashimoto Atsushi
Department Of Anesthesiology Aichi Medical University
-
Shinomiya Takashi
Department Of Pharmacology Tokyo Dental College
-
Kobayashi Hiroyuki
Department Of Anesthesiology Okayama Red Cross Hospital
-
TSUKAMOTO Hideo
Laboratory for Molecular Science Research, Tokai University School of Medicine
-
OKA Tetsuo
Department of Clinical Pharmacology, School of Medicine, Tokai University
関連論文
- Age and Sex-Dependent Alterations in Heart Rate Variability : Profiling the Characteristics of Men and Women in Their 30s
- Simvastatin reduces myocardial infarct size via increased nitric oxide production in normocholesterolemic rabbits
- PJ-163 Oxytocin Treatment after Myocardial Infarction Promotes Cardiac Repair and Neovascularization through Activation of Multiple Pro-survival Signals(PJ028,Cardiovascular Pharmacology (Basic), Cost-health care system/DPC/Laws (H),Poster Session (Japane
- FRS-043 Voglibose Reduces Myocardial Infarct Size via Stimulation of GLP-1 Receptors and PI3 kinase-Akt-eNOS Pathway in Rabbits(FRS9,Novel Mechanisms of Myocardial Ischemia (IHD),Featured Research Session (English),The 73rd Annual Scientific Meeting of Th
- PJ-723 The Anti-Diabetic Drug Voglibose Reduces Myocardial Infarct Size and Improves Left Ventricular Function via Production of Glucagon-like Peptide-1 in Rabbits(Myocardial ischemia / reperfusion, basic / clinical(04)(IHD),Poster Session(Japanese),The 7
- PE-228 Migritol Improve Myocardial Ischemia in Type 2 Diabetic Patients with Coronary Artery Disease(Nuclear cardiology(04)(I),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- OE-182 Oxytocin reduces myocardial infarct size and improves left ventricular function and remodeling through activation of Akt, VEGF, BCI-2 and Angiogenesis(Growth factor/Cytokine(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of th
- OE-070 Post-Infarct Treatment with an Erythropoietin-Gelatin Hydrogel Patchlmproves Cardiac Function by Activating Prosurvival Signaling and exerting Antifibrotic and Angiogenic Effects(Genetics/Genetically engineered models/Gene therapy(M),Oral Presentat
- OJ-254 Erythropoietin Drug Delivery System protects the heart against myocardial infarction through activation of Akt and angiogenesis(Growth factor/Cytokine-2(H/M), The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OE-128 Pioglitazone, an Anti-Diabetic Drug, Reduces Myocardial Infarct Size via Stimulating Peroxisome Proliferator Activated Receptor-γ (PPARγ) in Rabbits Model of Myocardial Infarction(Myocardial ischemia/reperfusion, basic/clinical-1, The 71st Annual S